Atherosclerosis in type 2 diabetes: a role for fibrate therapy?

  title={Atherosclerosis in type 2 diabetes: a role for fibrate therapy?},
  author={G. Steiner},
  journal={Diabetes & Vascular Disease Research},
  pages={368 - 374}
  • G. Steiner
  • Published 2007
  • Medicine
  • Diabetes & Vascular Disease Research
  • Vascular complications associated with type 2 diabetes confer significant morbidity and mortality. Atherosclerosis develops much earlier and progresses more rapidly than in subjects without diabetes. The clustering of cardiovascular risk factors associated with type 2 diabetes is mainly responsible for accelerated atherosclerotic disease. While statins remain the primary lipid-modifying therapy, the pharmacological profile of the fibrates suggests potential as an alternative or additional… CONTINUE READING
    25 Citations
    Small dense low-density lipoprotein-lowering agents
    Models to study atherosclerosis: a mechanistic insight.
    • 54
    • PDF
    Insulin Resistance and Mitochondrial Dysfunction.
    • 50
    Plasma Trimethylamine N-oxide and risk of cardiovascular events in patients with type 2 diabetes.
    • 2


    Impact of the atherosclerotic process in patients with diabetes
    • 35
    Endothelial inflammation in insulin resistance
    • 262
    Pharmacokinetic interactions between statins and fibrates.
    • 65
    Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods.
    • 427
    • PDF
    Fibrates in 2003: therapeutic action in atherogenic dyslipidaemia and future perspectives.
    • 183
    • Highly Influential
    The role of fibrates in managing hyperlipidemia: Mechanisms of action and clinical efficacy
    • 106
    Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels.
    • 418
    Insulin resistance and atherosclerosis.
    • 170
    • PDF
    Lipids, diabetes, and coronary heart disease: insights from the Framingham Study.
    • 642